Binding of Mucin by E. coli from Human Gut


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

Cells of E. coli isolates from the gut of healthy volunteers (N=5) and patients with Crohn’s disease (N=5) and laboratory E. coli strain DH5α bound mucin in vitro in similar amounts ranging from 0.02 to 0.12 mg/mg of bacterial dry weight. Binding was evaluated by the decrease in optical absorption of mucin solution at 214 nm after incubation with bacteria. Detailed analysis of mucin binding by one of isolates showed that during incubation of 0.09 mg/ml bacteria in 0.15 M NaCl containing 0.1 mg/ml mucin at 25oC, maximum binding was reached in 30 min, while in the presence of 14 mM α-methyl mannoside, mucin binding decreased by 46% (p<0.05). Confocal microscopy revealed intensive binding of FITC-labeled mucin to the surface of a small number of bacterial cells. Mucin binding did not significantly affect zeta potential of bacteria and their energetic status assessed by ATP content; at the same time, ATP content in the extracellular environment slightly increased.

作者简介

T. Vakhrusheva

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
俄罗斯联邦, Moscow

Yu. Baikova

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
俄罗斯联邦, Moscow

N. Balabushevich

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
俄罗斯联邦, Moscow

S. Gusev

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
俄罗斯联邦, Moscow

G. Lomakina

Faculty of Chemistry, M. V. Lomonosov Moscow State University

Email: lemik2007@yandex.ru
俄罗斯联邦, Moscow

E. Sholina

Faculty of Chemistry, M. V. Lomonosov Moscow State University

Email: lemik2007@yandex.ru
俄罗斯联邦, Moscow

M. Moshkovskaya

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
俄罗斯联邦, Moscow

P. Shcherbakov

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
俄罗斯联邦, Moscow

O. Pobeguts

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

Email: lemik2007@yandex.ru
俄罗斯联邦, Moscow

E. Mikhal’chik

Federal Research and Clinical Center for Physical-Chemical Medicine, Federal Medical-Biological Agency

编辑信件的主要联系方式.
Email: lemik2007@yandex.ru
俄罗斯联邦, Moscow


版权所有 © Springer Science+Business Media, LLC, part of Springer Nature, 2018
##common.cookie##